What starts as a story of death and ignorance becomes a chronicle of discovery and success. To mark its 25th anniversary, the Harvard AIDS Initiative created a short video outlining major accomplishments and the work that remains to be done.
TasP Africa Workshop
Treatment as Prevention in Africa (TasP Africa) was the first workshop devoted exclusively to treatment as prevention in Africa. TasP Africa brought together researchers in infectious disease, health leaders, policy makers, and drug industry representatives to review TasP efforts already underway in Africa, to receive updates on current studies, to consider difficulties in creating, monitoring and maintaining TasP programs, and to establish a TasP research agenda specific to Africa
Videos from TasP Africa
April 30 – May 3, 2014 • Gaborone, Botswana
- Dr. Laura Bogart: What is the Role of Behavioral and Social Factors in TasP?
- Dr. Heidi Van Rooyen: HIV Testing and TasP: Community Mobilization
- Dr. Ian Sanne: Update on Scale-Up of Treatment Programs in Southern Africa
- Dr. Nancy Padian: What Defines Success for TasP in Africa?
- Dr. Velephi Okello: MaxART: Immediate Access to ART for All Implementation Study
- Dr. Lisa Mills: TasP with Combination Prevention
- Dr. Joseph Makhema: Update on BHP TasP Trials
- Dr. Shahin Lockman: Success of PMTCT of HIV
- Dr. Johnstone Kumwenda: Review of HPTN052
- Dr. Salim Karim:ARVs for prevention in t-risk populations:Microbicides
- Dr. Saidi Kapiga: Scale-up of Treatment Programs in East Africa
- Dr. Phyllis Kanki: Antiretroviral Treatment in Nigeria: Implications for TasP
- Dr. Collins Iwuji: A cluster-randomised trial of treatment as prevention (TasP) in rural KwaZulu-Natal, South Africa: ANRS 12249 TasP
- Dr. Diane Havlir: Sustainable East Africa Research for Community Health
- Dr. Wafaa El Sadr: Treatment as Prevention in Africa: Prioritization of Population
- Dr. Richard Hayes: HPTN 071: Population effects of antiretroviral therapy to reduce HIV transmission (PopART) PART 1
- Dr. Helen Ayles: HPTN 071: Population effects of antiretroviral therapy to reduce HIV transmission (PopART) PART 2
World AIDS Day 2013
We asked Harvard School of Public Health students, faculty, and staff eight questions about AIDS. We wanted to know what they were thinking and feeling about the epidemic. We also wanted to know how aware they were of current HIV/AIDS statistics.
8 Questions about AIDS
December 1, 2013
AIDS@30
To commemorate the 30th anniversary of the epidemic, Harvard University convened a major international symposium in December 2011.
Videos from AIDS@30 on Vimeo
- Funding the Global AIDS Response
Moderator: Alan Brandt, Harvard Graduate School of Arts and Sciences
Perspective: Michel Kazatchkine, Global Fund to Fight AIDS, Tuberculosis and Malaria - Participants: Robert Hecht, Results for Development; Gregg Gonsalves, Harvard Medical School; John E. Tedstrom, GBCHealth; Ira C. Magaziner Clinton Health Access Initiative (CHAI);
- Is an HIV Vaccine Possible?
Moderator: Bruce Walker, Ragon Institute of MGH, MIT and Harvard
Perspective: Anthony Fauci, National Institutes of Health
Participants: Robert Gallo, University of Maryland; Juliana McElrath, University of Washington; Nelson Michael, Walter Reed Army Institute of Research; Jerald Sadoff, Crucell - The Future of HIV Prevention
Moderator: Max Essex, Harvard AIDS Initiative
Perspective: Wafaa El-Sadr, Columbia University, Mailman School of Public Health
Participants: Nancy Padian, University of California, Berkeley; Deborah Birx, CDC’s Center for Global Health; John C Pottage, ViiV Healthcare; Sharon L. Hillier, University of Pittsburgh School of Medicine; Robert Grant, Gladstone Institute of Virology and Immunology - International Mobilization and National Leadership
Moderator: Phyllis Kanki, Harvard School of Public Health
Perspective: Mariangela Simao, UNAIDS
Participants: Elly Katabira, International AIDS Society; Ambassador Anders Nordstrom, Sweden’s Ministry of Foreign Affairs; Suniti Solomon, Y.R. Gaitonde Centre - The Future of HIV Treatment
Moderator: Martin S. Hirsch, Harvard School of Public Health
Perspective: Jeffrey S. Murray, FDA
Participants: Daniel R. Kuritzkes, Brigham and Women’s Hospital; Dennis C. Liotta, Emory University; Roger Pomerantz, Merck; Wim Parys, Johnson & Johnson - Ending Pediatric AIDS
Moderator: Chip Lyons, Elizabeth Glaser Pediatric AIDS Foundation
Perspectives: Ambassador Eric Goosby, PEPFAR; Florence Ngobeni-Allen, Elizabeth Glaser Pediatric AIDS Foundation
Participants: Elaine Abrams, Columbia University; Angela Mushavi, Ministry of Health, Zimbabwe - Global and Local Health Disparities
Moderator: Phill Wilson, Black AIDS Institute
Perspectives: Paul Farmer, Partners In Health; Kenneth Mayer, Fenway Health
Participants: Dázon Dixon Diallo, SisterLove; Jean William Pape, GHESKIO; Jorge Saavedra, AIDS Healthcare Foundation
Max Essex Receives Lifetime Achievement Award
The Institute of Human Virology (IHV) at the University of Maryland School of Medicine presented its Lifetime Achievement Award for Scientific Contributions to Dr. Max Essex, Chair of the Harvard AIDS Initiative, in November 2011. Essex received the award “for his work on animal and human retrovirus research and his leadership and great impact in the public health of Botswana.”
Dr. Phyllis Kanki introduces Dr. Max Essex
Dr. Robert Gallo presents the award to Essex
Saturday Is for funerals
Saturday Is for Funerals, the book by Max Essex and Unity Dow, explores both the science of HIV/AIDS and the personal tragedies of those affected by the epidemic in southern Africa.
